Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ophthalmology

Free Subscription Articles published in Surv Ophthalmol Retrieve available abstracts of 183 articles: HTML format

Single Articles

November 2025
1. BHATTI MT, Moore JG, Hwang TN, Bilyk JR, et al
   Blow.
   Surv Ophthalmol. 2025;70:1261-1266.
   PubMed     Abstract available
   
   
   
2. COUTURIER A, Wykoff CC, Lupidi M, Udaondo P, et al
   Anatomic biomarkers as potential endpoints in diabetic macular edema: A systematic literature review with identification of macular volume as a key surrogate for visual acuity.
   Surv Ophthalmol. 2025;70:1090-1110.
   PubMed     Abstract available
   
   
   
3. ZHANG P, Xu Z
   The advancements in precision medicine for Leber congenital amaurosis: Breakthroughs from genetic diagnosis to therapy.
   Surv Ophthalmol. 2025;70:1205-1219.
   PubMed     Abstract available
   
   
   
4. LEE SH, Ho YR, Li H, Tu YK, et al
   Prevalence and clinical manifestations of cytomegalovirus infection in patients with Posner-Schlossman syndrome: A systematic review and meta-analysis.
   Surv Ophthalmol. 2025;70:1252-1260.
   PubMed     Abstract available
   
   
   September 2025
5. TSENG YH, Wu PL, Kang EY, Chen KJ, et al
   Advancements in ocular blood flow imaging: Clinical applications of laser speckle flowgraphy and optical coherence tomography angiography in retinal and choroidal vascular diseases.
   Surv Ophthalmol. 2025 Sep 21:S0039-6257(25)00180.
   PubMed     Abstract available
   
   
   
6. SABOYA-GALINDO P, Cifuentes-Gonzalez C, Rojas-Carabali W, Mejia-Salgado G, et al
   Clinical trials and quasi-experimental studies in the treatment of noninfectious retinal vasculitis: A Systematic Review from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) - Report 4.
   Surv Ophthalmol. 2025 Sep 20:S0039-6257(25)00173.
   PubMed     Abstract available
   
   
   
7. LEE E, Hunt D, Cakir Y, Kuo D, et al
   Artificial intelligence in age-related macular degeneration: Advancing diagnosis, prognosis, and treatment.
   Surv Ophthalmol. 2025 Sep 18:S0039-6257(25)00174.
   PubMed     Abstract available
   
   
   
8. SUGANYA DEVI K, Vasireddi HK, Reddy GR, Satti SK, et al
   Unfolding the diagnostic pipeline of diabetic retinopathy with artificial intelligence: A systematic review.
   Surv Ophthalmol. 2025 Sep 17:S0039-6257(25)00170.
   PubMed     Abstract available
   
   
   
9. CIFUENTES-GONZALEZ CG, Putera I, Walter CFY, Mejia-Salgado MS, et al
   Work-up in patients with retinal vasculitis: A systematic review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 2.
   Surv Ophthalmol. 2025 Sep 17:S0039-6257(25)00175.
   PubMed     Abstract available
   
   
   
10. LA ROSA A, Feo A, Bousquet E, Cabral D, et al
    Angioid streaks-related choroidal neovascularization: Clinical features, multimodal imaging-based differential diagnosis, and optimized treatment strategies.
    Surv Ophthalmol. 2025 Sep 17:S0039-6257(25)00169.
    PubMed     Abstract available
    
    
    
11. NANJI K, Hatamnejad A, Grad J, El-Sayes A, et al
    Visual outcomes associated with optical coherence tomography biomarkers in diabetic macular edema: A systematic review.
    Surv Ophthalmol. 2025 Sep 17:S0039-6257(25)00176.
    PubMed     Abstract available
    
    
    
12. KOCAK I, Sayin N, Bayramoglu SE, Thalib L, et al
    Effect of methotrexate in preventing retinal detachment after proliferative vitreoretinopathy surgery: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Sep 16:S0039-6257(25)00177.
    PubMed     Abstract available
    
    
    
13. SUMODHEE D, Ioannidou E, Ramessur R, Prashar J, et al
    Interventions to improve patients' knowledge in ophthalmology: A systematic review and narrative synthesis.
    Surv Ophthalmol. 2025 Sep 13:S0039-6257(25)00168.
    PubMed     Abstract available
    
    
    
14. LOH NC, Rojas-Carabali W, Lim YH, Bong JE, et al
    Choroidal Vascularity Index as a marker of health and disease: Systematic review and meta-Analyses.
    Surv Ophthalmol. 2025 Sep 5:S0039-6257(25)00164.
    PubMed     Abstract available
    
    
    
15. HATAMNEJAD A, Nanji K, Grad J, El-Sayes A, et al
    Predicting Treatment Response in Retinal Vein Occlusions Using Baseline Optical Coherence Tomography Biomarkers: A Systematic Review.
    Surv Ophthalmol. 2025 Sep 4:S0039-6257(25)00148.
    PubMed     Abstract available
    
    
    
16. SONG W, Chen W, Chi J, Liu X, et al
    The role of lipid metabolism disorder in the progression and treatment of ocular vascular diseases.
    Surv Ophthalmol. 2025 Sep 4:S0039-6257(25)00163.
    PubMed     Abstract available
    
    
    
17. LIU C, Yan R, Jiang J
    Adjustable suture versus nonadjustable suture surgery for childhood strabismus: A meta-analysis.
    Surv Ophthalmol. 2025;70:859-867.
    PubMed     Abstract available
    
    
    
18. CARLA MM, Ripa M, Crincoli E, Catania F, et al
    The spectrum of microcystic macular edema: Pathogenetic insights, clinical entities, and functional prognosis.
    Surv Ophthalmol. 2025;70:982-994.
    PubMed     Abstract available
    
    
    
19. JEAN-CHARLES S, Shoji MK, Kikkawa DO, Bhatti MT, et al
    The mirrored arterial dilemma.
    Surv Ophthalmol. 2025;70:1029-1033.
    PubMed     Abstract available
    
    
    August 2025
20. GIANNOPOULOS NG, Macri CZ, Seneviratne IAK, Bacchi S, et al
    A narrative review of the psychological impact of intravitreal injections.
    Surv Ophthalmol. 2025 Aug 28:S0039-6257(25)00144.
    PubMed     Abstract available
    
    
    
21. MOZAFAR M, Fekrazad S, Amanollahi M, Samiee R, et al
    Optical coherence tomography angiography measurements in thyroid eye disease: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Aug 20:S0039-6257(25)00143.
    PubMed     Abstract available
    
    
    
22. MALOOF AG, Zhang S, Pavic NV, Coroneo MT, et al
    'Seeing both sides': A systematic review of the Miyake-Apple video system's role in Ophthalmology.
    Surv Ophthalmol. 2025 Aug 20:S0039-6257(25)00134.
    PubMed     Abstract available
    
    
    
23. QIAN Y, Lin X, Wang Y, Mao Y, et al
    In vivo detection of macrophage-like cells at the vitreoretinal interface in retinal diseases using optical coherence tomography angiography.
    Surv Ophthalmol. 2025 Aug 19:S0039-6257(25)00141.
    PubMed     Abstract available
    
    
    
24. LE NVA, Nguyen NC, Kasetsuwan N, Reinprayoon U, et al
    Corrigendum to "Penetrating keratoplasty versus deep anteriror lamellar keratoplasty for macular corneal dystrophy: A meta-analysis" [Survey Ophthalomol., vol. 70 (2025) P480-488/ PMID: 39709033].
    Surv Ophthalmol. 2025 Aug 18:S0039-6257(25)00137.
    PubMed    
    
    
    
25. SEN M, Munier FL, Honavar SG
    Intraocular seeds in retinoblastoma: A review of classification, management, and outcomes.
    Surv Ophthalmol. 2025 Aug 15:S0039-6257(25)00139.
    PubMed     Abstract available
    
    
    
26. RAJESWAREN V, Trivedi V, Yoganathan P
    Macular hole after anti-Vascular Endothelial Growth factor injection: A review.
    Surv Ophthalmol. 2025 Aug 14:S0039-6257(25)00140.
    PubMed     Abstract available
    
    
    
27. PARIS JE, Macri CZ, Lake SR, Chan WO, et al
    Risk factors for retinal breaks following surgical induction of posterior vitreous detachment: A scoping review.
    Surv Ophthalmol. 2025 Aug 12:S0039-6257(25)00138.
    PubMed     Abstract available
    
    
    
28. DIRANI K, Kim C, Park J, Gregory A, et al
    Clinical Implications of heavy silicon oil (Densiron(R)) endotamponade after pars plana vitrectomy: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Aug 7:S0039-6257(25)00132.
    PubMed     Abstract available
    
    
    
29. GAO J, Wang W, Mo Y
    Retinal Degenerative Diseases: Complement system-Microglia Crosstalk.
    Surv Ophthalmol. 2025 Aug 5:S0039-6257(25)00135.
    PubMed     Abstract available
    
    
    July 2025
30. HE M, Yang Z, Shi Z, Chen Y, et al
    Clinical features, management, and prognosis factors of traumatic optic neuropathy.
    Surv Ophthalmol. 2025 Jul 30:S0039-6257(25)00129.
    PubMed     Abstract available
    
    
    
31. CARLA MM, Mottola F, Cusato M, Oreste G, et al
    Vitreoretinal interface abnormalities in age-related macular degeneration: Prevalence, pathophysiology, and reciprocal influence.
    Surv Ophthalmol. 2025 Jul 23:S0039-6257(25)00126.
    PubMed     Abstract available
    
    
    
32. DRAKOPOULOS M, Nadel A, Bains HK, Bisen JB, et al
    Quantitative ophthalmic posterior segment optical coherence tomography angiography and systemic conditions.
    Surv Ophthalmol. 2025 Jul 21:S0039-6257(25)00123.
    PubMed     Abstract available
    
    
    
33. ZHANG HY, Smith AW, Laferriere HE, Finn AP, et al
    The use of time-driven activity-based costing in ophthalmology: A scoping review.
    Surv Ophthalmol. 2025 Jul 19:S0039-6257(25)00122.
    PubMed     Abstract available
    
    
    
34. JIN K, Yu T, Grzybowski A
    Multimodal artificial intelligence in ophthalmology: Applications, challenges, and future directions.
    Surv Ophthalmol. 2025 Jul 17:S0039-6257(25)00120.
    PubMed     Abstract available
    
    
    
35. SUH A, Szeto JJ, Ong J, Armstrong GW, et al
    Ocular trauma in microgravity: In-flight diagnostics and extraterrestrial strategies for management.
    Surv Ophthalmol. 2025 Jul 15:S0039-6257(25)00124.
    PubMed     Abstract available
    
    
    
36. CARLA MM, Couturier A, Mottola F, Cusato M, et al
    The influence of scleral buckle on choroidal architecture: An unexplored link with the spectrum of acquired overload choroidopathy?
    Surv Ophthalmol. 2025 Jul 9:S0039-6257(25)00108.
    PubMed     Abstract available
    
    
    
37. WAN Y, Guo X, Wang N
    Trabecular meshwork: A pivotal target for evolving glaucoma treatments.
    Surv Ophthalmol. 2025 Jul 8:S0039-6257(25)00107.
    PubMed     Abstract available
    
    
    
38. VILARES-MORGADO R, Verbruggen K, Stalmans I, Barbosa-Breda J, et al
    Age-related changes in optical coherence tomography glaucoma-related parameters: A systematic review.
    Surv Ophthalmol. 2025 Jul 3:S0039-6257(25)00104.
    PubMed     Abstract available
    
    
    
39. KHOSRAVI MIRZAEI S, Hatami F, Safi S, Khorrami Z, et al
    Pharmacological agents for treatment of proliferative vitreoretinopathy: A systematic review and network meta-analysis.
    Surv Ophthalmol. 2025;70:633-644.
    PubMed     Abstract available
    
    
    
40. JAIN M, Mohankumar A, Torres J, Alkorbi HA, et al
    Pharmacological associations of central serous chorioretinopathy: Looking beyond corticosteroids.
    Surv Ophthalmol. 2025;70:616-632.
    PubMed     Abstract available
    
    
    
41. ARRUDA MP, Hira S, Lima RV, Barbosa LIT, et al
    Pharmacological therapy for relieving pain in panretinal photocoagulation: A network meta-analysis of randomized controlled trials.
    Surv Ophthalmol. 2025;70:645-652.
    PubMed     Abstract available
    
    
    
42. SHETH JU, Stewart MW, Narayanan R, Anantharaman G, et al
    Macular neovascularization.
    Surv Ophthalmol. 2025;70:653-675.
    PubMed     Abstract available
    
    
    
43. WOUDSTRA-DE JONG JE, Busschbach JJ, Manning-Charalampidou SS, Vingerling JR, et al
    Assessment of patient-reported outcomes in vitreomacular interface disorders: A systematic literature review.
    Surv Ophthalmol. 2025;70:685-694.
    PubMed     Abstract available
    
    
    
44. MELENDEZ-MORENO A, Yesiltas YS, Jacquelyn Wrenn NP, Singh AD, et al
    Corrigendum to "Iris melanoma: Prognostication for metastasis"[Survey Ophthalmol 68 (2023) 957-963].
    Surv Ophthalmol. 2025 Jul 1:S0039-6257(25)00106.
    PubMed    
    
    
    June 2025
45. SONG A, Lee E, Ostmo SR, Jonas KE, et al
    Retinopathy of prematurity training and education: A systematic review.
    Surv Ophthalmol. 2025 Jun 18:S0039-6257(25)00102.
    PubMed     Abstract available
    
    
    
46. VON DER EMDE L, Petzinna SM, Herwig-Carl MC, Adamson MS, et al
    Advances in diagnosing and treating giant cell arteritis: New hope for arteritic anterior ischemic optic neuropathy.
    Surv Ophthalmol. 2025 Jun 18:S0039-6257(25)00103.
    PubMed     Abstract available
    
    
    
47. YANG WYL, Wong HJ, Fu CE, Rojas-Carabali W, et al
    Artificial intelligence in the prediction of glaucoma development and progression: A systematic review.
    Surv Ophthalmol. 2025 Jun 18:S0039-6257(25)00105.
    PubMed     Abstract available
    
    
    
48. HAMMOUD B, Schumacher JS, Zhang H, Dutra BAL, et al
    Brillouin microscopy for focal biomechanical measurements in normal and keratoconic corneas: A narrative review.
    Surv Ophthalmol. 2025 Jun 11:S0039-6257(25)00099.
    PubMed     Abstract available
    
    
    
49. TOVEY CRUTCHFIELD EC, Vincent AL, Anjou MD, Taylor HR, et al
    Inherited retinal disease in global Indigenous populations: A scoping review.
    Surv Ophthalmol. 2025 Jun 11:S0039-6257(25)00101.
    PubMed     Abstract available
    
    
    
50. WOO J, Chopra S, Liu K, Tuttle B, et al
    Impact of neighborhood-level deprivation on glaucoma prevalence and treatment: A review of the literature.
    Surv Ophthalmol. 2025 Jun 10:S0039-6257(25)00100.
    PubMed     Abstract available
    
    
    
51. HAN L, Mao Y, Sang Q, Wan Y, et al
    Efficacy and complications of microcatheter-assisted minimally invasive glaucoma surgery for open-angle glaucoma: A systematic review and network meta-analysis.
    Surv Ophthalmol. 2025 Jun 6:S0039-6257(25)00097.
    PubMed     Abstract available
    
    
    May 2025
52. ALKHABAZ A, Pujari R, Ren Y, Smith SJ, et al
    Optic disc drusen-associated neovascularization: A systematic review.
    Surv Ophthalmol. 2025 May 27:S0039-6257(25)00095.
    PubMed     Abstract available
    
    
    
53. CHEN KY, Chan HC, Chan CM
    Effectiveness and safety of anti-vascular endothelial growth factor therapies for macular edema in retinal vein occlusion: A systematic review and network meta-analysis of randomized controlled trials.
    Surv Ophthalmol. 2025 May 24:S0039-6257(25)00096.
    PubMed     Abstract available
    
    
    
54. KHAN MMH, Akhlaq A, Khan MJ, Ali M, et al
    Impact of social determinants of health on causes of ophthalmic trauma: A narrative review.
    Surv Ophthalmol. 2025 May 24:S0039-6257(25)00091.
    PubMed     Abstract available
    
    
    
55. RAHMANIPOUR E, Sadeghi E, Arora S, Ghorbani M, et al
    Choroidal hypopigmented lesions: A review.
    Surv Ophthalmol. 2025 May 14:S0039-6257(25)00073.
    PubMed     Abstract available
    
    
    
56. SINGH SR, Sadeghi E, Vupparaboina KK, Chhablani J, et al
    Recent updates in choroidal imaging biomarkers.
    Surv Ophthalmol. 2025 May 13:S0039-6257(25)00075.
    PubMed     Abstract available
    
    
    
57. ERDAG M, Citirik M, Dal A
    Augmented and virtual reality in retinal care: A systematic review of their role in training, surgery, and treatment.
    Surv Ophthalmol. 2025 May 10:S0039-6257(25)00072.
    PubMed     Abstract available
    
    
    
58. CHRONOPOULOS A, Schutz JS, Finger RP
    Prevention of rhegmatogenous retinal detachment.
    Surv Ophthalmol. 2025 May 6:S0039-6257(25)00071.
    PubMed     Abstract available
    
    
    
59. CIFUENTES-GONZALEZ C, Le Tong Y, Rojas-Carabali W, Mejia-Salgado G, et al
    Systematic Review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 3.
    Surv Ophthalmol. 2025 May 2:S0039-6257(25)00066.
    PubMed     Abstract available
    
    
    
60. SADEGHI E, Colorado-Zavala MF, Almuhtaseb H, Venkatesh R, et al
    Anatomical and functional changes after internal limiting membrane peeling.
    Surv Ophthalmol. 2025;70:357-368.
    PubMed     Abstract available
    
    
    
61. CHOPRA P, Fatima A, Mohapatra S, Murugaiyan K, et al
    Extracellular vesicles in dry eye disease and Sjogren's syndrome: A systematic review on their diagnostic and therapeutic role.
    Surv Ophthalmol. 2025;70:499-515.
    PubMed     Abstract available
    
    
    April 2025
62. TAN JK, Steel DH, Ahmad S, Viswanathan A, et al
    Exploring the potential of Rho kinase inhibitors in ophthalmology: From mechanisms to clinical practice.
    Surv Ophthalmol. 2025 Apr 16:S0039-6257(25)00058.
    PubMed     Abstract available
    
    
    
63. GRASSMEYER JJ, Pennesi ME, Yang P, Tschetter W, et al
    Effects of medications on the human electroretinogram: A comprehensive review.
    Surv Ophthalmol. 2025 Apr 12:S0039-6257(25)00067.
    PubMed     Abstract available
    
    
    
64. UCAR F
    Comment on: "Postoperative complications of intrascleral intraocular lens fixation: A systematic review and meta-analysis".
    Surv Ophthalmol. 2025 Apr 3:S0039-6257(25)00065.
    PubMed    
    
    
    March 2025
65. MASTROGIUSEPPE E, Alisi L, Romaniello A, Caterino L, et al
    Managing Cutibacterium acnes endophthalmitis after cataract surgery: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Mar 29:S0039-6257(25)00061.
    PubMed     Abstract available
    
    
    
66. AGARWAL A, Vempuluru VS, Kaliki S
    Primary Ocular, Adnexal, and Orbital Rhabdomyosarcoma: A Review.
    Surv Ophthalmol. 2025 Mar 27:S0039-6257(25)00060.
    PubMed     Abstract available
    
    
    
67. HUNG JH, Jain T, Khatri A, Nguyen TB, et al
    Inherited retinal diseases-associated uveitis.
    Surv Ophthalmol. 2025 Mar 27:S0039-6257(25)00057.
    PubMed     Abstract available
    
    
    
68. SHAIKH N, Kumawat D, Chandra P, Senthil S, et al
    Glaucoma in retinopathy of prematurity - A review.
    Surv Ophthalmol. 2025 Mar 25:S0039-6257(25)00056.
    PubMed     Abstract available
    
    
    
69. SIT AJ, Aihara M, Khawaja AP, Lin SC, et al
    Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors.
    Surv Ophthalmol. 2025 Mar 17:S0039-6257(25)00052.
    PubMed     Abstract available
    
    
    
70. GHALEB R, Sallam AB, Grigorian F, Phillips PH, et al
    Oral fluorescein angiography in pediatric ophthalmology.
    Surv Ophthalmol. 2025 Mar 13:S0039-6257(25)00051.
    PubMed     Abstract available
    
    
    
71. CHEN Y, Jiang F, Zeng Y, Zhang M, et al
    The role of retinal pigment epithelial senescence and the potential of senotherapeutics in age-related macular degeneration.
    Surv Ophthalmol. 2025 Mar 13:S0039-6257(25)00053.
    PubMed     Abstract available
    
    
    
72. YAO A, Hussain A, Kannan R, Nduka C, et al
    Dynamic procedures for eyelid involvement in facial nerve palsy.
    Surv Ophthalmol. 2025 Mar 13:S0039-6257(25)00054.
    PubMed     Abstract available
    
    
    
73. RODRIGUEZ-GARCIA A, Ruiz-Lozano RE, Barcelo-Canton RH, Marines-Sanchez HM, et al
    The Etiologic and Pathogenic Spectrum of Exposure Keratopathy: Diagnostic and Therapeutic Implications.
    Surv Ophthalmol. 2025 Mar 8:S0039-6257(25)00050.
    PubMed     Abstract available
    
    
    
74. RICKELS KL, Ghaleb R, Elhusseiny AM, Chauhan MZ, et al
    Ocular manifestations secondary to cocaine abuse.
    Surv Ophthalmol. 2025 Mar 5:S0039-6257(25)00032.
    PubMed     Abstract available
    
    
    
75. NEFFENDORF JE, Jackson TL
    Presumed phototoxicity from macular vital staining with Brilliant Blue G and Trypan Blue: A post-market surveillance study, systematic review, and synthesis of the literature.
    Surv Ophthalmol. 2025;70:339-351.
    PubMed     Abstract available
    
    
    
76. LEI Y, Wang Y, Tang S, Yang J, et al
    The adaptive immune system in the retina of diabetics.
    Surv Ophthalmol. 2025;70:241-254.
    PubMed     Abstract available
    
    
    
77. BHATTI MT, Fors DH, Muminovic I, Robbins SL, et al
    Heavy duty.
    Surv Ophthalmol. 2025;70:352-355.
    PubMed     Abstract available
    
    
    
78. ZHANG Q, Wang S, Wang X, Xu C, et al
    Advancing Ophthalmology With Large Language Models: Applications, Challenges, and Future Directions.
    Surv Ophthalmol. 2025 Mar 1:S0039-6257(25)00037.
    PubMed     Abstract available
    
    
    February 2025
79. DUNNIGAN JK, Wang CY, George L, Lee VA, et al
    Social Media in Ophthalmology: A Comprehensive Literature Review.
    Surv Ophthalmol. 2025 Feb 22:S0039-6257(25)00031.
    PubMed     Abstract available
    
    
    
80. GHAFARIAN S, Samavat B, Lee K, Sheikhghomi S, et al
    Clinical strategies to prevent recurrence of Herpes simplex and Herpes zoster following ocular surgery: A comprehensive review with practical guidelines.
    Surv Ophthalmol. 2025 Feb 15:S0039-6257(25)00029.
    PubMed     Abstract available
    
    
    
81. AL-DABET S, Turaev S, Zaki N
    Ocular-Induced Abnormal Head Postures: A Systematic Review and Analysis.
    Surv Ophthalmol. 2025 Feb 9:S0039-6257(25)00021.
    PubMed     Abstract available
    
    
    
82. ZHANG C, Lai D, Zhu D, Palka C, et al
    Chlorhexidine for ocular antisepsis before intravitreal injection: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Feb 6:S0039-6257(25)00024.
    PubMed     Abstract available
    
    
    
83. CIFUENTES-GONZALEZ C, Le Tong Y, Mejia-Salgado G, Chan R, et al
    Global demographic and etiological variations of retinal vasculitis: A systematic review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 1.
    Surv Ophthalmol. 2025 Feb 5:S0039-6257(25)00023.
    PubMed     Abstract available
    
    
    January 2025
84. YANG Z, Tian D, Xie Z, Cheng T, et al
    Clinical features, diagnosis, management, and prognosis of circumscribed choroidal hemangioma.
    Surv Ophthalmol. 2025 Jan 23:S0039-6257(25)00011.
    PubMed     Abstract available
    
    
    
85. SADEGHI E, Rahmanipour E, Valsecchi N, Kapoor S, et al
    An update on ocular effects of antidiabetic medications.
    Surv Ophthalmol. 2025 Jan 22:S0039-6257(25)00019.
    PubMed     Abstract available
    
    
    
86. TURCAS C, Nicoara SD
    A comprehensive review of structure-function correlations in age-related macular degeneration: Contributions of microperimetry.
    Surv Ophthalmol. 2025 Jan 17:S0039-6257(25)00017.
    PubMed     Abstract available
    
    
    
87. ORTIZ-MORALES G, Ruiz-Lozano RE, Morales-Mancillas N, Homar Paez-Garza J, et al
    Pediatric blepharokeratoconjunctivitis: A challenging ocular surface disease.
    Surv Ophthalmol. 2025 Jan 17:S0039-6257(25)00009.
    PubMed     Abstract available
    
    
    
88. BAYAT K, Pooyan P, Looha MA, Namakin K, et al
    Retinal structural alterations in patients with epilepsy taking antiepileptic drugs: A systematic review and meta-analysis of OCT findings.
    Surv Ophthalmol. 2025 Jan 15:S0039-6257(25)00012.
    PubMed     Abstract available
    
    
    
89. FORTE P, Paques M, Cattaneo J, Dupas B, et al
    Perifoveal vascular anomalous complex and telangiectatic capillaries: An overview of two entities potentially sharing a common pathophysiology.
    Surv Ophthalmol. 2025 Jan 15:S0039-6257(25)00014.
    PubMed     Abstract available
    
    
    
90. FEO A, Stradiotto E, Govetto A, Forte P, et al
    Bacillary layer detachment: Updates on its clinical and prognostic significance in retinal disease.
    Surv Ophthalmol. 2025 Jan 14:S0039-6257(25)00013.
    PubMed     Abstract available
    
    
    
91. DE LOTT LB, Kaplan C, Harte S, Clauw DJ, et al
    Nociplastic pain among individuals with chronic ocular surface pain: one cause for "pain without stain"?
    Surv Ophthalmol. 2025 Jan 13:S0039-6257(25)00015.
    PubMed     Abstract available
    
    
    
92. LIU T, Elnahry AG, Tauqeer Z, Yu Y, et al
    Incidence and risk factors of perioperative suprachoroidal hemorrhage: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025;70:54-62.
    PubMed     Abstract available
    
    
    
93. YANG W, Ren R, Xie Y, Wang J, et al
    Diabetic uveopathy.
    Surv Ophthalmol. 2025;70:47-53.
    PubMed     Abstract available
    
    
    
94. BHATTI MT, Long JR, Carey AR
    Denial.
    Surv Ophthalmol. 2025;70:162-166.
    PubMed     Abstract available
    
    
    December 2024
95. LIN TH, Lin HY, Tseng PC
    Enhancing anti-vascular endothelial growth factor with photodynamic therapy for polypoidal choroidal vasculopathy: A meta-analysis.
    Surv Ophthalmol. 2024 Dec 19:S0039-6257(24)00157.
    PubMed     Abstract available
    
    
    
96. NGOC VAN ANH L, Ngoc Cong N, Ngamjit K, Usanee R, et al
    Penetrating keratoplasty versus deep anteriror lamellar keratoplasty for macular corneal dystrophy: A meta-analysis.
    Surv Ophthalmol. 2024 Dec 19:S0039-6257(24)00156.
    PubMed     Abstract available
    
    
    
97. SERVILLO A, Scandale P, Oldoni G, Begar PG, et al
    Inflammatory choroidal neovascularization: An evidence-based update.
    Surv Ophthalmol. 2024 Dec 18:S0039-6257(24)00155.
    PubMed     Abstract available
    
    
    
98. JIRAVARNSIRIKUL A, Belghith A, Rezapour J, Bowd C, et al
    Evaluating glaucoma in myopic eyes: Challenges and opportunities.
    Surv Ophthalmol. 2024 Dec 17:S0039-6257(24)00154.
    PubMed     Abstract available
    
    
    
99. SANTINA A, Feo A, Bousquet E, Velaga SB, et al
    Pentosan polysulfate sodium maculopathy: Final analysis of a prospective cohort, updated review, and association with inflammatory bowel disease.
    Surv Ophthalmol. 2024 Dec 12:S0039-6257(24)00153.
    PubMed     Abstract available
    
    
    
100. NAGINO K, Inomata T, Ohta T, Sung J, et al
     Postoperative complications of intrascleral intraocular lens fixation: A systematic review and meta-analysis.
     Surv Ophthalmol. 2024 Dec 12:S0039-6257(24)00152.
     PubMed     Abstract available
     
     
     November 2024
101. EIJGEN JV, Winckel LV, Hanssen H, Kotliar K, et al
     Retinal vessel analysis to assess microvascular function in the healthy eye: A systematic review on the response to acute physiological and pathological stressors.
     Surv Ophthalmol. 2024 Nov 24:S0039-6257(24)00140.
     PubMed     Abstract available
     
     
     
102. RAI BB, Maddess T, Nolan CJ
     Functional diabetic retinopathy: A new concept to improve management of diabetic retinal diseases.
     Surv Ophthalmol. 2024 Nov 23:S0039-6257(24)00142.
     PubMed     Abstract available
     
     
     
103. ISSA M, Sukkarieh G, Gallardo M, Sarbout I, et al
     Applications of artificial intelligence to inherited retinal diseases: A systematic review.
     Surv Ophthalmol. 2024 Nov 18:S0039-6257(24)00139.
     PubMed     Abstract available
     
     
     
104. LEE SJV, FRCOphth, Goh YQ, Rojas-Carabali W, et al
     Association between retinal vessels caliber and systemic health: A comprehensive review.
     Surv Ophthalmol. 2024 Nov 16:S0039-6257(24)00138.
     PubMed     Abstract available
     
     
     
105. VAHEB S, Panah MY, Shaygannejad V, Zabeti A, et al
     Uveitis among people with multiple sclerosis: A systematic review and meta-analysis.
     Surv Ophthalmol. 2024 Nov 15:S0039-6257(24)00134.
     PubMed     Abstract available
     
     
     
106. PUTERA I, Distia Nora R, Dewi AC, Suhada DS, et al
     Antiviral therapy for cytomegalovirus retinitis: A systematic review and meta-analysis.
     Surv Ophthalmol. 2024 Nov 14:S0039-6257(24)00141.
     PubMed     Abstract available
     
     
     
107. RIZZO C, Savastano MC, Kilian R, Marchini G, et al
     Structural en face optical coherence tomography in neovascular and nonneovascularage-related macular degeneration: Use and utility in clinical practice.
     Surv Ophthalmol. 2024 Nov 8:S0039-6257(24)00135.
     PubMed     Abstract available
     
     
     
108. LI L, Xiao K, Shang X, Hu W, et al
     Advances in artificial intelligence for meibomian gland evaluation: A comprehensive review.
     Surv Ophthalmol. 2024;69:945-956.
     PubMed     Abstract available
     
     
     October 2024
109. ELSAYED MEA, Lander B, Senthil S, Edward DP, et al
     The Secondary Childhood Glaucomas.
     Surv Ophthalmol. 2024 Oct 30:S0039-6257(24)00132.
     PubMed     Abstract available
     
     
     
110. SADEGHI E, Valsecchi N, Rahmanipour E, Ejlalidiz M, et al
     Choroidal biomarkers in age-related macular degeneration.
     Surv Ophthalmol. 2024 Oct 17:S0039-6257(24)00131.
     PubMed     Abstract available
     
     
     
111. ALBRECHT M, Auffarth GU, Friedrich M, Kessler LJ, et al
     Vision degrading myodesopsia from vitreous floaters in the young: An important aspect of myopia.
     Surv Ophthalmol. 2024 Oct 16:S0039-6257(24)00128.
     PubMed     Abstract available
     
     
     
112. NEWMAN NJ, Biousse V, Yu-Wai-Man P, Carelli V, et al
     Meta-analysis of treatment outcomes for patients with m.11778G>A MT-ND4 Leber Hereditary Optic Neuropathy.
     Surv Ophthalmol. 2024 Oct 15:S0039-6257(24)00130.
     PubMed     Abstract available
     
     
     
113. GUPTA Y, Devi C, Priyadarshini K, Mandal S, et al
     Pediatric Keratoconus.
     Surv Ophthalmol. 2024 Oct 11:S0039-6257(24)00129.
     PubMed     Abstract available
     
     
     
114. HOVEN E, Michelet JT, Vettore MV, Lagali N, et al
     Choroidal thickness after anti-VEGF in typical neovascular age-related macular degeneration - A systematic review and meta-analysis.
     Surv Ophthalmol. 2024 Oct 5:S0039-6257(24)00124.
     PubMed     Abstract available
     
     
     September 2024
115. MIKHAIL D, Milad D, Antaki F, Hammamji K, et al
     The role of artificial intelligence in macular hole management: A scoping review.
     Surv Ophthalmol. 2024 Sep 30:S0039-6257(24)00123.
     PubMed     Abstract available
     
     
     
116. BERMAN G, Pendley AM, Wright DW, Silverman R, et al
     Breaking the barriers: Methodology of implementation of a non-mydriatic ocular fundus camera in an emergency department.
     Surv Ophthalmol. 2024 Sep 30:S0039-6257(24)00127.
     PubMed     Abstract available
     
     
     
117. TAN JCK, Yohannan J, Ramulu PY, Kalloniatis M, et al
     Visual field testing in glaucoma using the Swedish Interactive Threshold Algorithm.
     Surv Ophthalmol. 2024 Sep 28:S0039-6257(24)00118.
     PubMed     Abstract available
     
     
     
118. STALHAMMAR G, Hagstrom A, Ermedahl Conradi M, Williams PA, et al
     Choroidal nevi and melanoma doubling times and implications for delays in treatment: A systematic review and meta-analysis.
     Surv Ophthalmol. 2024 Sep 28:S0039-6257(24)00117.
     PubMed     Abstract available
     
     
     
119. ALISI L, Giovannetti F, Armentano M, Lucchino L, et al
     Challenging corneal diseases and miRNA expression: Focus on rare diseases and new therapeutic frontiers.
     Surv Ophthalmol. 2024 Sep 27:S0039-6257(24)00120.
     PubMed     Abstract available
     
     
     
120. FERRO DESIDERI L, Sim PY, Bernardi E, Paschon K, et al
     Evidence-based guidelines for drug dosing in intravitreal injections in silicone oil-filled eyes: Pharmacokinetics, safety, and optimal dosage.
     Surv Ophthalmol. 2024 Sep 27:S0039-6257(24)00119.
     PubMed     Abstract available
     
     
     
121. D'ALBENZIO A, Komici K, Affatato M, Castelluzzo AM, et al
     Vitreous Cortex Remnants in Patients With Rhegmatogenous Retinal Detachment: A Systematic Review and Meta-analysis.
     Surv Ophthalmol. 2024 Sep 26:S0039-6257(24)00121.
     PubMed     Abstract available
     
     
     
122. LEI C, Lv Z, Hua R, Duan J, et al
     Focal choroidal excavation: Review and updated pathogenesis.
     Surv Ophthalmol. 2024 Sep 25:S0039-6257(24)00126.
     PubMed     Abstract available
     
     
     
123. YANG Q, Ju G, He Y
     Corneal densitometry: New evaluation indicator for corneal diseases.
     Surv Ophthalmol. 2024 Sep 24:S0039-6257(24)00122.
     PubMed     Abstract available
     
     
     
124. WANG K, Liu Y, Li S, Zhao N, et al
     Unveiling the therapeutic potential and mechanisms of stanniocalcin-1 in retinal degeneration.
     Surv Ophthalmol. 2024 Sep 11:S0039-6257(24)00085.
     PubMed     Abstract available
     
     
     
125. SUH A, Ditelberg S, Szeto JJ, Kumar D, et al
     Safety protocols, precautions, and countermeasures aboard the International Space Station (ISS) to prevent ocular injury.
     Surv Ophthalmol. 2024 Sep 3:S0039-6257(24)00097.
     PubMed     Abstract available
     
     
     
126. L'ABBATE D, Prescott K, Geraghty B, Kearns VR, et al
     Biomechanical considerations for optimising subretinal injections.
     Surv Ophthalmol. 2024;69:722-732.
     PubMed     Abstract available
     
     
     
127. TAWFIK HA, Ali MJ
     A major review on punctal stenosis: Part II: Updated therapeutic interventions, complications, and outcomes.
     Surv Ophthalmol. 2024;69:756-768.
     PubMed     Abstract available
     
     
     
128. BIRCH EE, Duffy KR
     Leveraging neural plasticity for the treatment of amblyopia.
     Surv Ophthalmol. 2024;69:818-832.
     PubMed     Abstract available
     
     
     
129. CHEN JS, Korn BS, Carey AR, Savino PJ, et al
     Looking beyond blurred margins.
     Surv Ophthalmol. 2024;69:842-846.
     PubMed     Abstract available
     
     
     August 2024
130. CHAUHAN K, Dave VP, de Ribot FM, Agrawal R, et al
     Traumatic retinal detachment: A contemporary update.
     Surv Ophthalmol. 2024 Aug 31:S0039-6257(24)00101.
     PubMed     Abstract available
     
     
     
131. MANO F, LoBue S, Tailor P, Olsen TW, et al
     Incisional choroidal surgery.
     Surv Ophthalmol. 2024 Aug 31:S0039-6257(24)00096.
     PubMed     Abstract available
     
     
     
132. JESSUP AJC, Coroneo MT
     Examining the fabric of the eye: Antoni van Leeuwenhoek, the draper and ocular microscopist.
     Surv Ophthalmol. 2024 Aug 28:S0039-6257(24)00098.
     PubMed     Abstract available
     
     
     
133. ZHAO Q, Wei L, Chen Y
     Detection of choroidal vascular features in diabetic patients without clinically visible diabetic retinopathy by optical coherence tomography angiography: A systemic review and meta-analysis.
     Surv Ophthalmol. 2024 Aug 28:S0039-6257(24)00100.
     PubMed     Abstract available
     
     
     
134. SURICO PL, Barone V, Singh RB, Coassin M, et al
     Potential applications of mesenchymal stem cells in ocular surface immune-mediated disorders.
     Surv Ophthalmol. 2024 Aug 1:S0039-6257(24)00083.
     PubMed     Abstract available
     
     
     
135. SCHLOESSER L, Klose SM, Mauschitz MM, Abdullah Z, et al
     The role of immune modulators in age-related macular degeneration.
     Surv Ophthalmol. 2024 Aug 1:S0039-6257(24)00084.
     PubMed     Abstract available
     
     
     July 2024
136. MARMOR MF
     Lupus review is misleading about risk of hydroxychloroquine retinal toxicity.
     Surv Ophthalmol. 2024 Jul 24:S0039-6257(24)00082.
     PubMed    
     
     
     
137. ZHANG Z, Shan X, Li S, Chang J, et al
     Retinal light damage: From mechanisms to protective strategies.
     Surv Ophthalmol. 2024 Jul 23:S0039-6257(24)00079.
     PubMed     Abstract available
     
     
     
138. VUJOSEVIC S, Lupidi M, Donati S, Astarita C, et al
     Role of inflammation in diabetic macular edema and neovascular age-related macular degeneration.
     Surv Ophthalmol. 2024 Jul 17:S0039-6257(24)00080.
     PubMed     Abstract available
     
     
     
139. FOUAD YA, Cicinelli MV, Marchese A, Casalino G, et al
     Revisiting acute retinal pigment epitheliitis (Krill disease).
     Surv Ophthalmol. 2024 Jul 16:S0039-6257(24)00078.
     PubMed     Abstract available
     
     
     
140. TORKASHVAND A, Izadian A, Hajrasouliha A
     Advances in Ophthalmic Therapeutic Delivery: A Comprehensive Overview of Present and Future Directions.
     Surv Ophthalmol. 2024 Jul 8:S0039-6257(24)00076.
     PubMed     Abstract available
     
     
     
141. HASHEMI E, Looha MA, Mazaherinia H, Samadaeian N, et al
     Risk of stroke development following retinal vein occlusion: A systematic review and meta-analysis.
     Surv Ophthalmol. 2024 Jul 3:S0039-6257(24)00074.
     PubMed     Abstract available
     
     
     
142. SINCLAIR SH, Schwartz S
     Diabetic retinopathy: New concepts of screening, monitoring, and interventions.
     Surv Ophthalmol. 2024 Jul 2:S0039-6257(24)00077.
     PubMed     Abstract available
     
     
     
143. WU H, Jin K, Yip CC, Koh V, et al
     A systematic review of economic evaluation of artificial intelligence-based screening for eye diseases: From possibility to reality.
     Surv Ophthalmol. 2024;69:499-507.
     PubMed     Abstract available
     
     
     
144. BUNJO LJ, Bacchi S, Pietris J, Chan WO, et al
     Current management options for the treatment of refractory postoperative cystoid macular edema: A systematic review.
     Surv Ophthalmol. 2024;69:606-621.
     PubMed     Abstract available
     
     
     
145. LEIDY L, Dickinson A, Ramulu P, Ehrlich J, et al
     Clinical outcome measures in vision and eye care.
     Surv Ophthalmol. 2024;69:632-637.
     PubMed     Abstract available
     
     
     June 2024
146. HOSSEINI F, Asadi F, Rabiei R, Kiani F, et al
     Applications of artificial intelligence in diagnosis of uncommon cystoid macular edema using optical coherence tomography imaging: A systematic review.
     Surv Ophthalmol. 2024 Jun 26:S0039-6257(24)00073.
     PubMed     Abstract available
     
     
     
147. PARRAVANO M, Cennamo G, Di Antonio L, Grassi MO, et al
     Multimodal imaging in diabetic retinopathy and macular edema: An update about biomarkers.
     Surv Ophthalmol. 2024 Jun 26:S0039-6257(24)00075.
     PubMed     Abstract available
     
     
     
148. DAUNGSUPAWONG H, Wiwanitkit V
     Generative artificial intelligence in ophthalmology: Correspondence.
     Surv Ophthalmol. 2024 Jun 17:S0039-6257(24)00071.
     PubMed    
     
     
     
149. FARAHAT Z, Zrira N, Souissi N, Bennani Y, et al
     Diabetic retinopathy screening through artificial intelligence algorithms: A systematic review.
     Surv Ophthalmol. 2024 Jun 15:S0039-6257(24)00051.
     PubMed     Abstract available
     
     
     
150. POSARELLI M, Passaro ML, Avolio FC, Costagliola C, et al
     The incidence of severe complications in acanthamoeba keratitis: Qualitative and quantitative systematic assessment.
     Surv Ophthalmol. 2024 Jun 15:S0039-6257(24)00069.
     PubMed     Abstract available
     
     
     
151. WAISBERG E, Ong J, Masalkhi M, Lee AG, et al
     Future directions of generative artificial intelligence in ophthalmology and vision science.
     Surv Ophthalmol. 2024 Jun 14:S0039-6257(24)00072.
     PubMed    
     
     
     May 2024
152. BACHMEIER I, Armendariz BG, Yu S, Jager RJ, et al
     Corrigendum to "Fibrosis in neovascular age-related macular degeneration: a review of definitions based on clinical imaging" [Surv Ophthalmol 68 (2023) 835-848/5].
     Surv Ophthalmol. 2024 May 28:S0039-6257(23)00137.
     PubMed    
     
     
     
153. HERNANDEZ RF, Rodriguez JEM, Trecu MS, Tariq Bhatti M, et al
     Not everything is ischemic optic neuropathy.
     Surv Ophthalmol. 2024 May 23:S0039-6257(24)00054.
     PubMed     Abstract available
     
     
     
154. VEMPULURU VS, Maniar A, Bakal K, Kaliki S, et al
     Role of MYCN in Retinoblastoma: A Review of Current Literature.
     Surv Ophthalmol. 2024 May 23:S0039-6257(24)00055.
     PubMed     Abstract available
     
     
     
155. CHENG T, Gu X, Yang Z, Wang C, et al
     Clinical features of ocular damage in systemic lupus erythematosus and risk factors of hydroxychloroquine related complications.
     Surv Ophthalmol. 2024 May 21:S0039-6257(24)00052.
     PubMed     Abstract available
     
     
     
156. KNECHT KT, Chiriac G, Guan HD
     The potential impact of a vegetarian diet on glaucoma.
     Surv Ophthalmol. 2024 May 18:S0039-6257(24)00048.
     PubMed     Abstract available
     
     
     
157. WAISBERG E, Ong J, Kamran SA, Masalkhi M, et al
     Generative artificial intelligence in ophthalmology.
     Surv Ophthalmol. 2024 May 16:S0039-6257(24)00044.
     PubMed     Abstract available
     
     
     
158. FEKRAZAD S, Hassanzadeh G, Salehi MA, Mozafar M, et al
     Optical coherence tomography angiography measurements in systemic lupus erythematosus: A systematic review and meta-analysis.
     Surv Ophthalmol. 2024 May 12:S0039-6257(24)00047.
     PubMed     Abstract available
     
     
     
159. TRINCAO-MARQUES TM, Ayton LN, Hickey DG, Marques-Neves C, et al
     Gene and cell therapy for age-related macular degeneration: A review.
     Surv Ophthalmol. 2024 May 10:S0039-6257(24)00049.
     PubMed     Abstract available
     
     
     
160. NIAZI S, Doroodgar F, Nazari SH, Rahimi Y, et al
     Refractive surgical approaches to keratoconus: A systematic review and network meta-analysis.
     Surv Ophthalmol. 2024 May 4:S0039-6257(24)00045.
     PubMed     Abstract available
     
     
     
161. TAWFIK HA, Ali MJ
     A major review of punctal stenosis: Updated anatomy, epidemiology, etiology, and clinical presentation.
     Surv Ophthalmol. 2024;69:441-455.
     PubMed     Abstract available
     
     
     
162. HUANG RS, Mihalache A, Popovic MM, Cruz-Pimentel M, et al
     Diagnostic methods for primary vitreoretinal lymphoma: A systematic review.
     Surv Ophthalmol. 2024;69:456-464.
     PubMed     Abstract available
     
     
     
163. ROY R, Chattree S, Kala U, Majumdar B, et al
     Multicolor imaging: Current clinical applications.
     Surv Ophthalmol. 2024;69:378-402.
     PubMed     Abstract available
     
     
     
164. ARORA S, Zur D, Iovino C, Chhablani J, et al
     Peripapillary fluid: Obvious and not so obvious!
     Surv Ophthalmol. 2024;69:311-329.
     PubMed     Abstract available
     
     
     
165. PELLEGRINI F, Basciu M, Foroozan R
     Planet of the apex.
     Surv Ophthalmol. 2024;69:495-498.
     PubMed     Abstract available
     
     
     April 2024
166. VERA-DUARTE GR, Jimenez-Collado D, Kahuam-Lopez N, Ramirez-Miranda A, et al
     Neurotrophic keratopathy: General features and new therapies.
     Surv Ophthalmol. 2024 Apr 26:S0039-6257(24)00042.
     PubMed     Abstract available
     
     
     
167. LEE YM, Bahrami B, Selva D, Casson RJ, et al
     Scoping review of non-surgical treatment options for macular holes.
     Surv Ophthalmol. 2024 Apr 25:S0039-6257(24)00043.
     PubMed     Abstract available
     
     
     
168. KANG C, Lee MJ, Chomsky A, Oetting TA, et al
     Risk factors for complications in resident-performed cataract surgery: A systematic review.
     Surv Ophthalmol. 2024 Apr 20:S0039-6257(24)00032.
     PubMed     Abstract available
     
     
     
169. SALEHI MA, Frounchi N, Zakavi SS, Mohammadi S, et al
     Retinal and choroidal changes after anti-VEGF therapy in Neovascular-AMD Patients: A Systematic Review and Meta-Analysis of SD-OCT studies.
     Surv Ophthalmol. 2024 Apr 17:S0039-6257(24)00033.
     PubMed     Abstract available
     
     
     
170. KROLO I, Behaegel J, Termote K, de Bruyn B, et al
     The role of topical insulin on ocular surface restoration: A review.
     Surv Ophthalmol. 2024 Apr 10:S0039-6257(24)00031.
     PubMed     Abstract available
     
     
     March 2024
171. ARDA H, Maier M, Schultheiss M, Haritoglou C, et al
     Advances in management strategies for large and persistent macular hole: an update.
     Surv Ophthalmol. 2024 Mar 27:S0039-6257(24)00030.
     PubMed     Abstract available
     
     
     
172. NOURI H, Abtahi SH, Mazloumi M, Samadikhadem S, et al
     Optical coherence tomography angiography in diabetic retinopathy: A major review.
     Surv Ophthalmol. 2024 Mar 21:S0039-6257(24)00021.
     PubMed     Abstract available
     
     
     
173. BRESSLER NM, Kaiser PK, Do DV, Nguyen QD, et al
     Biosimilars of anti-vascular endothelial growth factor for ophthalmic diseases: A review.
     Surv Ophthalmol. 2024 Mar 21:S0039-6257(24)00029.
     PubMed     Abstract available
     
     
     
174. SCHEFFER M, Menting J, Boeije H, van Nispen R, et al
     Understanding healthcare communication in age-related macular degeneration care: A mixed-methods review of patients' perspectives.
     Surv Ophthalmol. 2024 Mar 16:S0039-6257(24)00018.
     PubMed     Abstract available
     
     
     
175. SABATINO F, Banerjee P, K Muqit MM
     Clinical therapeutics for proliferative vitreoretinopathy in retinal detachment.
     Surv Ophthalmol. 2024 Mar 15:S0039-6257(24)00024.
     PubMed     Abstract available
     
     
     
176. ANG T, Chaggar V, Tong JY, Selva D, et al
     Medication-associated orbital inflammation: A systematic review.
     Surv Ophthalmol. 2024 Mar 13:S0039-6257(24)00020.
     PubMed     Abstract available
     
     
     
177. ORTIZ-SELLER A, Martorell P, Barranco H, Pascual-Camps I, et al
     Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis.
     Surv Ophthalmol. 2024 Mar 1:S0039-6257(24)00008.
     PubMed     Abstract available
     
     
     
178. OO HH, Mohan M, Song W, Rojas-Carabali W, et al
     Anterior chamber inflammation grading methods: A critical review.
     Surv Ophthalmol. 2024;69:253-264.
     PubMed     Abstract available
     
     
     
179. YESILTAS YS, Oakey Z, Wrenn J, Yeaney G, et al
     Uveal melanoma in African Americans: Diagnostic challenges.
     Surv Ophthalmol. 2024;69:190-197.
     PubMed     Abstract available
     
     
     
180. ARNOLD RW
     Surgical and anesthetic influences of the oculocardiac reflex in adults and children during strabismus surgery.
     Surv Ophthalmol. 2024;69:295.
     PubMed    
     
     
     
181. ROBBINS SL, Greenberg M, Juan I
     Surgical and anesthetic influences of the oculocardiac reflex in adults and children during strabismus surgery.
     Surv Ophthalmol. 2024;69:S0039-625700087-5.
     PubMed    
     
     
     February 2024
182. JIANG F, Lei C, Chen Y, Zhou N, et al
     The complement system and diabetic retinopathy.
     Surv Ophthalmol. 2024 Feb 23:S0039-6257(24)00007.
     PubMed     Abstract available
     
     
     September 2023
183. PELLEGRINI F, Basciu M, Falardeau J
     Pole to pole.
     Surv Ophthalmol. 2023;68:1002-1005.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ophthalmology is free of charge.